Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, Talha Bin Emran, Saikat Mitra, Ali A. Rabaan, Saad Alhumaid, Zainab Al Alawi & Abbas Al Mutair. (2022) COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Articles from other publishers (54)
Vivek P. Varma, Mohammad Kadivella, Sridhar Kavela & Syed M. Faisal. (2023) Leptospira Lipid A Is a Potent Adjuvant That Induces Sterilizing Immunity against Leptospirosis. Vaccines 11:12, pages 1824.
Crossref
Crossref
Nomfundo Ntombela, Matome Matsiela, Sbahle Zuma, Suhavna Hiralal, Leeann Naicker, Nobalanda Mokoena & Thandeka Khoza. (2023) Production of recombinant lumpy skin disease virus A27L and L1R proteins for application in diagnostics and vaccine development. Vaccine: X 15, pages 100384.
Crossref
Crossref
Nagarajan Usharani, Swarna V. Kanth & Natarajan Saravanan. (2023) Biomimetic nanomaterials for pulmonary infections: A prospective view in drug delivery systems. Applied Nanoscience.
Crossref
Crossref
Saurav Kumar Jha, Mohammad Imran, Laxmi Akhileshwar Jha, Nazeer Hasan, Vijay Kumar Panthi, Keshav Raj Paudel, Waleed H. Almalki, Yousuf Mohammed & Prashant Kesharwani. (2023) A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response. Environmental Research 236, pages 116823.
Crossref
Crossref
Juhienah K. Khalaf, Laura S. Bess, Lois M. Walsh, Janine M. Ward, Craig L. Johnson, Mark T. Livesay, Konner J. Jackson, Jay T. Evans, Kendal T. Ryter & Hélène G. Bazin-Lee. (2023) Diamino Allose Phosphates: Novel, Potent, and Highly Stable Toll-like Receptor 4 Agonists. Journal of Medicinal Chemistry 66:20, pages 13900-13917.
Crossref
Crossref
Trevor Ung, Nakisha S. Rutledge, Adam M. Weiss, Aaron P. Esser-Kahn & Peter Deak. (2023) Cell-targeted vaccines: implications for adaptive immunity. Frontiers in Immunology 14.
Crossref
Crossref
Anna Jéssica Duarte Silva, Mylenna Máyra Gois de Sousa, Larissa Silva de Macêdo, Pedro Luiz de França Neto, Ingrid Andrêssa de Moura, Benigno Cristofer Flores Espinoza, Maria Da Conceição Viana Invenção, Samara Sousa de Pinho, Marco Antonio Turiah Machado da Gama & Antonio Carlos de Freitas. (2023) RNA Vaccines: Yeast as a Novel Antigen Vehicle. Vaccines 11:8, pages 1334.
Crossref
Crossref
Yang Hao, Zhonghao Ji, Hengzong Zhou, Dongrun Wu, Zili Gu, Dongxu Wang & Peter ten Dijke. (2023) Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy. MedComm 4:4.
Crossref
Crossref
João Guilherme Lino da Silva, Ana Alice Maia Gonçalves, Liliam Teixeira Oliveira, Giani Martins Garcia, Maurício Azevedo Batista, Ludmila Zanandreis de Mendonça, Kelvinson Fernandes Viana, Rita de Cássia Oliveira Sant’Ana, Otoni Alves de Oliveira Melo Júnior, Denise Silveira-Lemos, Walderez Ornelas Dutra, Olindo Assis Martins-Filho, Alexsandro Sobreira Galdino, Sandra Aparecida Lima de Moura, Vanessa Carla Furtado Mosqueira & Rodolfo Cordeiro Giunchetti. (2023) Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity. Vaccines 11:8, pages 1309.
Crossref
Crossref
Tingmei Zhao, Yulong Cai, Yujie Jiang, Xuemei He, Yuquan Wei, Yifan Yu & Xiaohe Tian. (2023) Vaccine adjuvants: mechanisms and platforms. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Mahnoosh Maleki, Seyed Masoud Hosseini, Behrokh Farahmand, Maryam Saleh, Hadiseh Shokouhi, Ali Torabi & Fatemeh Fotouhi. (2023) Induction of Homosubtypic and Heterosubtypic Immunity to Influenza Viruses Using a Conserved Internal and External Proteins. Current Microbiology 80:6.
Crossref
Crossref
Sarthak M. Shah, Devyani Joshi, Christiane Chbib, Monzurul A. Roni & Mohammad N. Uddin. (2023) The Autoinducer N-Octanoyl-L-Homoserine Lactone (C8-HSL) as a Potential Adjuvant in Vaccine Formulations. Pharmaceuticals 16:5, pages 713.
Crossref
Crossref
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, Ankit Gupta, Rupesh Aggarwal, Rino Rappuoli & Atul Kumar Johri. (2023) New-age vaccine adjuvants, their development, and future perspective. Frontiers in Immunology 14.
Crossref
Crossref
Mohammed Ali Bakkari, Sivakumar S. Moni, Abdulrahman Alshammari, Muhammad H. Sultan, Osama A. Madkhali, Yosif Almoshari, Mohammad Firoz Alam & Mohamed Eltaib Elmobark. (2023) Induction of Innate and Adaptive Immune Response against Recombinant HBsAg Protein Entrapped in Docosahexaenoic Acid Nanovesicles through Biomarkers. Vaccines 11:2, pages 457.
Crossref
Crossref
Doaa E. Said, Eglal I. Amer, Eman Sheta, Shaimaa Makled, Fadwa M. Arafa & Hala E. Diab. (2023) Nano-Encapsulated Antioxidant: Retinoic Acid as a Natural Mucosal Adjuvant for Intranasal Immunization against Chronic Experimental Toxoplasmosis. Tropical Medicine and Infectious Disease 8:2, pages 106.
Crossref
Crossref
Siva K. Gandhapudi, Hua Shi, Martin R. Ward, John Peyton Bush, Margarita Avdiushko, Karuna Sundarapandiyan, Lauren V. Wood, Mania Dorrani, Afsheen Fatima, Joe Dervan, Frank Bedu-Addo, Greg Conn, Ted M. Ross & Jerold G. Woodward. (2023) Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice. Viruses 15:2, pages 432.
Crossref
Crossref
Piotr Rzymski, Agnieszka Szuster‐Ciesielska, Tomasz Dzieciątkowski, Willis Gwenzi & Andrzej Fal. (2023) mRNA vaccines: The future of prevention of viral infections?. Journal of Medical Virology 95:2.
Crossref
Crossref
Angelina Kovalenko, Ekaterina Ryabchevskaya, Ekaterina Evtushenko, Nikolai Nikitin & Olga Karpova. (2023) Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress. International Journal of Molecular Sciences 24:2, pages 1701.
Crossref
Crossref
Shinya Inoue, Izuru Mizoguchi, Jukito Sonoda, Eri Sakamoto, Yasuhiro Katahira, Hideaki Hasegawa, Aruma Watanabe, Yuma Furusaka, Mingli Xu, Toshihiko Yoneto, Naoki Sakaguchi, Kazuhiro Terai, Kunihiko Yamashita & Takayuki Yoshimoto. (2022)
Induction of potent antitumor immunity by intradermal
DNA
injection using a novel needle‐free pyro‐drive jet injector
. Cancer Science 114:1, pages 34-47.
Crossref
Crossref
Rani S. Sellers & Keith Nelson. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology
335
396
.
Hardeep Kaur, Virender Kumar, Rakesh Kumar Marwaha, Gajendra Singh & Davinder Kumar. 2023. Nanovaccinology. Nanovaccinology
331
342
.
Narges Lotfalizadeh, Soheil Sadr, Safa Moghaddam, Mahdis Saberi Najjar, Amin Khakshoor & Pouria Ahmadi Simab. (2022) The Innate Immunity Defense against Gastrointestinal Nematodes: Vaccine Development. Farm Animal Health and Nutrition 1:2, pages 31-38.
Crossref
Crossref
Patrick Syntin, Fabienne Piras-Douce, François Dalençon, Marie Garinot & Jean Haensler. (2022) Nonclinical safety assessments of a novel synthetic toll-like receptor 4 agonist and saponin based adjuvant. Toxicology and Applied Pharmacology, pages 116358.
Crossref
Crossref
Doaa E. Said, Eglal I. Amer, Eman Sheta, Shaimaa Makled, Hala E. Diab & Fadwa M. Arafa. (2022) Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection. Tropical Medicine and Infectious Disease 7:12, pages 401.
Crossref
Crossref
Carl Britto & Galit Alter. (2022) The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design. Current Opinion in Immunology 78, pages 102234.
Crossref
Crossref
Sazzad Shahrear & Abul Bashar Mir Md. Khademul Islam. (2022) Modeling of MT. P495, an mRNA-based vaccine against the phosphate-binding protein PstS1 of Mycobacterium tuberculosis. Molecular Diversity.
Crossref
Crossref
Zhi Cao, Ke Zhang, Heng Zhang, Hongliang Zhang, Ying Yu, Dehua Yin, Hu Shan & Zhihua Qin. (2022) Efficacy of a gB + gD-based subunit vaccine and the adjuvant granulocyte-macrophage colony stimulating factor for pseudorabies virus in rabbits. Frontiers in Microbiology 13.
Crossref
Crossref
Fatemeh Ghafouri, Reza Ahangari Cohan, Hilda Samimi, Ali Hosseini Rad S M, Mahmood Naderi, Farshid Noorbakhsh & Vahid Haghpanah. (2022) Development of a Multiepitope Vaccine Against SARS-CoV-2: Immunoinformatics Study. JMIR Bioinformatics and Biotechnology 3:1, pages e36100.
Crossref
Crossref
Jingyi Fan, Shengbin Jin, Lachlan Gilmartin, Istvan Toth, Waleed M. Hussein & Rachel J. Stephenson. (2022) Advances in Infectious Disease Vaccine Adjuvants. Vaccines 10:7, pages 1120.
Crossref
Crossref
Faith H. N. Howard, Amy Kwan, Natalie Winder, Amina Mughal, Cristal Collado-Rojas & Munitta Muthana. (2022) Understanding Immune Responses to Viruses—Do Underlying Th1/Th2 Cell Biases Predict Outcome?. Viruses 14:7, pages 1493.
Crossref
Crossref
QiangQiang Wang, Tahir Aleem Muhammad, Waqqas Hasan Muhammad, Ali Memon Muhammad, Haseeb Muhammad, RuoFeng Yan, LiXin Xu, XiaoKai Song & XiangRui Li. (2022) Hepatocellular carcinoma-associated antigen 59 and ADP-ribosylation factor 1 with poly (lactic-co-glycolic acid): A promising candidate as nanovaccine against haemonchosis. Microbial Pathogenesis 168, pages 105614.
Crossref
Crossref
Mohammed Ali Bakkari, Sivakumar S. Moni, Abdulrahman Alshammari, Ahmad Salawi, Muhammad H. Sultan, Osama A. Madkhali, Saad S. Alqahtani, Mohammad Firoz Alam, Emad Sayed Shaheen & Mohamed Eltaib Elmobark. (2022) Design, Characterization, and Immune Augmentation of Docosahexaenoic Acid Nanovesicles as a Potential Delivery System for Recombinant HBsAg Protein. Vaccines 10:6, pages 954.
Crossref
Crossref
Kou Hioki, Tomoya Hayashi, Yayoi Natsume-Kitatani, Kouji Kobiyama, Burcu Temizoz, Hideo Negishi, Hitomi Kawakami, Hiroyuki Fuchino, Etsushi Kuroda, Cevayir Coban, Nobuo Kawahara & Ken J. Ishii. (2022) Machine Learning-Assisted Screening of Herbal Medicine Extracts as Vaccine Adjuvants. Frontiers in Immunology 13.
Crossref
Crossref
Chriselle D. Braganza, Kristel Kodar, Thomas Teunissen, Sarah K. Andreassend, Ayesha Khan, Mattie S. M. Timmer & Bridget L. Stocker. (2022) Lipophilic glucose monoesters and glycosides are potent human Mincle agonists. Organic & Biomolecular Chemistry 20:15, pages 3096-3104.
Crossref
Crossref
Michelle H. Teplensky, Max E. Distler, Caroline D. Kusmierz, Michael Evangelopoulos, Haley Gula, Derek Elli, Anastasia Tomatsidou, Vlad Nicolaescu, Ian Gelarden, Anjana Yeldandi, Daniel Batlle, Dominique Missiakas & Chad A. Mirkin. (2022) Spherical nucleic acids as an infectious disease vaccine platform. Proceedings of the National Academy of Sciences 119:14.
Crossref
Crossref
Anna S. Karyagina, Alexander V. Gromov, Tatyana M. Grunina, Alexander M. Lyaschuk, Maria S. Poponova, Denis A. Kleymenov, Natalia V. Strukova, Maria S. Generalova, Anna V. Ryazanova, Zoya M. Galushkina, Olga Yu. Dobrynina, Tatyana N. Bolshakova, Maria V. Sergeeva, Ekaterina A. Romanovskaya-Romanko, Igor V. Krasilnikov, Marina E. Subbotina & Vladimir G. Lunin. (2022) Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization. Biochemistry (Moscow) 87:4, pages 319-330.
Crossref
Crossref
Erica L. Stewart, Claudio Counoupas, Matt D. Johansen, Duc H. Nguyen, Stefan Miemczyk, Nicole G. Hansbro, Kia C. Ferrell, Anneliese Ashhurst, Sibel Alca, Caroline Ashley, Megan Steain, Warwick J. Britton, Philip M. Hansbro, Nikolai Petrovsky & James A. Triccas. (2022) Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2. Mucosal Immunology 15:6, pages 1405-1415.
Crossref
Crossref
Dafei Chai, Dong Qiu, Xiaoqing Shi, Jiage Ding, Nan Jiang, Zichun Zhang, Jiawei Wang, Jie Yang, Pengli Xiao, Gang Wang & Junnian Zheng. (2022) Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity. Molecular Therapy - Oncolytics 24, pages 1-13.
Crossref
Crossref
Adélia Mendes, João Azevedo-Silva & João C. Fernandes. (2022) From Sharks to Yeasts: Squalene in the Development of Vaccine Adjuvants. Pharmaceuticals 15:3, pages 265.
Crossref
Crossref
Julieta Sandra CUEVAS-ROMERO, José Luis CERRITEÑO-SÁNCHEZ, Rocío LARA-ROMERO, Marco Antonio VEGA-LÓPEZ, Carmen RAMÍREZ-ESTUDILLO, Humberto RAMÍREZ-MENDOZA, Mikael BERG & Karin LÖVGREN-BENGTSSON. (2022) Immunogenicity of a recombinant hemagglutinin neuraminidase-<i>Porcine rubulavirus</i> produced by <i>Escherichia coli</i> of <i>Porcine rubulavirus</i> gives protective immunity of litter after challenge. Journal of Veterinary Medical Science 84:12, pages 1595-1604.
Crossref
Crossref
Tuyelee Das, Mimosa Ghorai, Uttpal Anand, Arabinda Ghosh, Potshangbam Nongdam, Mahipal S. Shekhawat, Devendra Kumar Pandey & Abhijit Dey. 2022. Nano-Strategies for Addressing Antimicrobial Resistance. Nano-Strategies for Addressing Antimicrobial Resistance
183
192
.
Hualin Li, Morgan A. Monslow, Daniel C. Freed, Dan Chang, Fengsheng Li, Marian Gindy, Dai Wang, Kalpit Vora, Amy S. Espeseth, Nikolai Petrovsky & Tong-Ming Fu. (2021) Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primates. Vaccine 39:51, pages 7446-7456.
Crossref
Crossref
Bon Il Koo, Seon‐Mi Jin, Hayeon Kim, Dong Jae Lee, Eunji Lee & Yoon Sung Nam. (2021) Conjugation‐Free Multilamellar Protein‐Lipid Hybrid Vesicles for Multifaceted Immune Responses. Advanced Healthcare Materials 10:22.
Crossref
Crossref
Javiera Villar, Michelle L. Salazar, José M. Jiménez, Miguel Del Campo, Augusto Manubens, María Alejandra Gleisner, Ignacio Ávalos, Flavio Salazar‐Onfray, Fabián Salazar, Daniel A Mitchell, Mohammad Y Alshahrani, Luisa Martínez‐Pomares & María Inés Becker. (2021) C‐type lectin receptors MR and DC‐SIGN are involved in recognition of hemocyanins, shaping their immunostimulatory effects on human dendritic cells. European Journal of Immunology 51:7, pages 1715-1731.
Crossref
Crossref
Honglei Wang, Yangyang Xu & Wenhai Feng. (2021) Porcine Reproductive and Respiratory Syndrome Virus: Immune Escape and Application of Reverse Genetics in Attenuated Live Vaccine Development. Vaccines 9:5, pages 480.
Crossref
Crossref
Roberto Fuentes, Ane Ruiz‐de‐Angulo, Nagore Sacristán, Claudio Daniel Navo, Gonzalo Jiménez‐Osés, Juan Anguita & Alberto Fernández‐Tejada. (2021) Replacing the Rhamnose‐Xylose Moiety of QS‐21 with Simpler Terminal Disaccharide Units Attenuates Adjuvant Activity in Truncated Saponin Variants. Chemistry – A European Journal 27:14, pages 4731-4737.
Crossref
Crossref
M. Laura Darriba, María L. Cerutti, Laura Bruno, Juliana Cassataro & Karina A. Pasquevich. (2021) Stability Studies of the Vaccine Adjuvant U-Omp19. Journal of Pharmaceutical Sciences 110:2, pages 707-718.
Crossref
Crossref
Jessamine E. Hazlewood, Troy Dumenil, Thuy T. Le, Andrii Slonchak, Stephen H. Kazakoff, Ann-Marie Patch, Lesley-Ann Gray, Paul M. Howley, Liang Liu, John D. Hayball, Kexin Yan, Daniel J. Rawle, Natalie A. Prow & Andreas Suhrbier. (2021) Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures. PLOS Pathogens 17:1, pages e1009215.
Crossref
Crossref
Ana Rita Franco & Francesco Peri. (2021) Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants. Cells 10:1, pages 78.
Crossref
Crossref
Neslihan Kayraklioglu, Begum Horuluoglu & Dennis M. Klinman. 2021. DNA Vaccines. DNA Vaccines
51
85
.
Samir Ghosh, Kevin R. Trabbic, Mengchao Shi, Sharmeen Nishat, Pradheep Eradi, Kristopher A. Kleski & Peter R. Andreana. (2020) Chemical synthesis and immunological evaluation of entirely carbohydrate conjugate Globo H-PS A1. Chemical Science 11:48, pages 13052-13059.
Crossref
Crossref
N. A. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya & L. A. Gayderova. (2020) General Characteristics of Adjuvants and Their Mechanism of Action (Part 1). BIOpreparations. Prevention, Diagnosis, Treatment 20:4, pages 245-256.
Crossref
Crossref
Maite Sainz-Mejías, Irene Jurado-Martín & Siobhán McClean. (2020) Understanding Pseudomonas aeruginosa–Host Interactions: The Ongoing Quest for an Efficacious Vaccine. Cells 9:12, pages 2617.
Crossref
Crossref
Sahra Bashiri, Prashamsa Koirala, Istvan Toth & Mariusz Skwarczynski. (2020) Carbohydrate Immune Adjuvants in Subunit Vaccines. Pharmaceutics 12:10, pages 965.
Crossref
Crossref